King Faisal Specialist Hospital & Research Centre

RIYADH, SAUDI ARABIA, November 28, 2025 / EINPresswire.com / -- King Faisal Specialist Hospital and Research Centre is preparing for a major expansion of its research enterprise, aiming to quadruple its capacity and surpass one thousand active interventional clinical trials within the next eight years. The plan reflects a broader shift toward a more coordinated system that aligns scientific discovery with clinical application. The hospital is strengthening its research structure to support the development of emerging therapies and diagnostics, focusing on areas where early discovery can translate more directly into patient care. This direction is shaping work on RNA based therapeutics, peptide based theranostics, and rapid molecular diagnostics designed to improve accuracy and turnaround time in clinical settings. The institution continues to advance in cell and gene therapy as well, having developed its own CAR T cell treatments for leukemia and lymphoma while expanding studies to additional disease areas. New research facilities are being planned to sustain this growth, including centers dedicated to interdisciplinary innovation and disease focused research across cancers, genetic disorders, neurological conditions, cardiovascular diseases, and infectious diseases. Close coordination with national research and regulatory bodies is intended to strengthen translational work and accelerate evaluation pathways for promising therapies and medical technologies. By consolidating core research, development, and clinical validation activities within a single ecosystem, the hospital aims to shorten the path from discovery to patient benefit and expand access to precision medicine across the region. KFSHRC is ranked first in the Middle East and Africa and fifteenth globally among the top 250 academic medical centers for 2025. It is also recognized as the most valuable healthcare brand in the Kingdom and the Middle East according to Brand Finance 2025 and is listed by Newsweek among the World’s Best Hospitals 2025, Best Smart Hospitals 2026, and Best Specialized Hospitals 2026. Riyadh King Faisal Specialist Hospital and Research Centre email us here Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

ٍRIYADH, SAUDI ARABIA, November 28, 2025 / EINPresswire.com / -- In a region where hereditary diseases appear more frequently than in many parts of the world, emerging genomic programs are helping clarify why certain conditions recur across extended families and how early intervention can influence long term outcomes. As part of this effort, King Faisal Specialist Hospital and Research Centre has expanded its work in rare disease genomics through programs that blend prevention, population specific sequencing, and focused investigation of inherited disorders. The approach reflects a broader strategy to ease the burden of genetic disease while improving diagnosis and treatment pathways. One of the central components of this work is the hospital’s Preimplantation Genetic Diagnosis program, which screens embryos for more than fifteen hundred genetic disorders. By identifying unaffected embryos before pregnancy, the program prevents hereditary diseases from being passed to future generations and offers families a preventive model that is uncommon in the region. Alongside this preventive effort, researchers are conducting large scale Whole Genome Sequencing to identify genetic markers relevant to populations in the region, where consanguinity contributes to higher rates of inherited conditions. The data generated through this sequencing supports earlier diagnosis and more individualized care for both rare disorders and widely prevalent illnesses such as cancer, cardiovascular disease, and diabetes. Recent findings illustrate the impact. Investigators diagnosed hereditary osteomalacia in thirty eight members of a single family across three generations, an insight that is shaping future clinical approaches and highlighting how complex conditions can remain undetected without genomic tools. The hospital also contributes nearly ten percent of all global entries in the Online Mendelian Inheritance in Man database, underscoring its role in documenting rare disorders worldwide. Its genomic work extends into infectious disease as well. Through whole genome sequencing, scientists identified a previously unknown species of antibiotic resistant bacteria known as Stenotrophomonas riyadhensis. The discovery adds to the global effort to understand antimicrobial resistance and informs research into emerging threats. King Faisal Specialist Hospital and Research Centre is ranked first in the Middle East and Africa and fifteenth globally among the top two hundred fifty academic medical centers for 2025. It is also recognized as the most valuable healthcare brand in the Kingdom and the Middle East according to Brand Finance 2025 and appears on Newsweek’s lists of the World’s Best Hospitals 2025, Best Smart Hospitals 2026, and Best Specialized Hospitals 2026. Riyadh King Faisal Specialist Hospital and Research Centre email us here Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

MADINAH, SAUDI ARABIA, November 28, 2025 / EINPresswire.com / -- King Faisal Specialist Hospital and Research Centre in Madinah has successfully removed a rare benign intramural bladder leiomyoma through a single-port incision measuring only 2 cm, without any abdominal opening. This achievement represents a pioneering application of an innovative surgical approach that provides patients with a safer and less painful option, reduces hospitalization duration, and accelerates recovery. This procedure enables complete removal of the tumor by providing direct visualization of the deep layers of the bladder wall. It reduces the need for pain medication, lowers the risk of complications, minimizes scarring, and shortens the duration of surgery, thereby expanding minimally invasive surgical options for rare and complex mural tumors. This advancement documents a new application of a known surgical approach, and for the first time it is used to excise an intramural smooth muscle tumor located within the bladder wall. Managing this type of tumor requires precise steps that include full circumferential dissection around the lesion, vascular control, margin management, and reconstruction of the internal bladder wall following excision. Traditionally, such cases required open abdominal surgery with an external incision into the bladder wall to access the tumor, an approach associated with increased pain, higher blood loss, longer hospitalization, and more visible scarring. In contrast, the single-port endoscopic technique allows direct access to the tumor from inside the bladder while preserving surrounding tissues and ensuring precise tumor removal. This achievement reflects the hospital’s ongoing commitment to developing advanced surgical solutions that elevate quality of care, enhance patient safety, and support national healthcare objectives under Saudi Vision 2030 in medical innovation and clinical excellence. KFSHRC is ranked first in the Middle East and Africa and fifteenth globally among the top 250 academic medical centers for 2025. It is also recognized as the most valuable healthcare brand in the Kingdom and the Middle East according to Brand Finance 2025 and is listed by Newsweek among the World’s Best Hospitals 2025, Best Smart Hospitals 2026, and Best Specialized Hospitals 2026. Madinah King Faisal Specialist Hospital and Research Centre email us here Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.